ADDC - AstraZeneca Collaboration

Contact Information:

Matthew Hartman

Academic Drug Discovery Consortium

Email: mhartman@addconsortium.org

For more information on Partnering With AstraZeneca http://www.astrazeneca.com/Partnering

Time Line
Fall 2018
Now accepting submissions for 2018. Deadline November 9th, 2018.
Fall 2018
Results anticipated December, 2018
Areas of Interest
Cardiovascular & Metabolic
Disease (CVMD)
Oncology
Neuroscience